OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
0.0390
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
OpGen Market Cap
OpGen has a market cap or net worth of $395.80 thousand as of August 1, 2025. Its market cap has decreased by -88.17% in one year.
Market Cap
395.80K
Enterprise Value
823.45K
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since May 5, 2015, OpGen's market cap has decreased from 51.90M to 395.80K, a decrease of -99.24%. That is a compound annual growth rate of -37.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2025 | 395.80K | -93.39% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | 45.88M | 1,069.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |